Home

Sedež podjetja Posojilodajalec Objemka versanis Namestitev žal mi je Slabost

Metal shoe shelf with upholstered seat. | Versanis.en
Metal shoe shelf with upholstered seat. | Versanis.en

Careers – Versanis
Careers – Versanis

Team – Versanis
Team – Versanis

Versanis Bio (@VersanisBio) / Twitter
Versanis Bio (@VersanisBio) / Twitter

Versanis Bio Logo | citybiz
Versanis Bio Logo | citybiz

Versanis – Transforming the treatment landscape for obesity and  cardiometabolic diseases
Versanis – Transforming the treatment landscape for obesity and cardiometabolic diseases

Versanis Bio - Crunchbase Company Profile & Funding
Versanis Bio - Crunchbase Company Profile & Funding

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of  Bimagrumab as a Novel Treatment for Obesity
Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity

Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in  obesity - MedCity News
Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in obesity - MedCity News

Versanis.de - Reviews | Facebook
Versanis.de - Reviews | Facebook

Versanis – Transforming the treatment landscape for obesity and  cardiometabolic diseases
Versanis – Transforming the treatment landscape for obesity and cardiometabolic diseases

Versanis Bio | LinkedIn
Versanis Bio | LinkedIn

Team – Versanis
Team – Versanis

Versanis Bio appoints Mark Pruzanski as CEO
Versanis Bio appoints Mark Pruzanski as CEO

Versanis Bio on Twitter: "Welcome to the Versanis Board of Directors, John  Maraganore @JMaraganore! John brings decades of proven strategic and  operational leadership experience in biotechnology to help Versanis realize  the full
Versanis Bio on Twitter: "Welcome to the Versanis Board of Directors, John Maraganore @JMaraganore! John brings decades of proven strategic and operational leadership experience in biotechnology to help Versanis realize the full

Versanis' bimagrumab, first-in-class obesity therapy, enters Phase IIb of  development - Pharmaceutical Technology
Versanis' bimagrumab, first-in-class obesity therapy, enters Phase IIb of development - Pharmaceutical Technology

About Us – Versanis
About Us – Versanis

News – Versanis
News – Versanis

Versanis Bio Announces Leadership and Board Appointments as Company  Prepares to Initiate Phase 2b Study with Novel Approach to Obesity
Versanis Bio Announces Leadership and Board Appointments as Company Prepares to Initiate Phase 2b Study with Novel Approach to Obesity

Versanis.de - Reviews | Facebook
Versanis.de - Reviews | Facebook

Pipeline – Versanis
Pipeline – Versanis

Versanis Bio | LinkedIn
Versanis Bio | LinkedIn

Access versanis.pl. Sklep internetowy z meblami | Wyposażenie wnętrz |  Versanis.pl
Access versanis.pl. Sklep internetowy z meblami | Wyposażenie wnętrz | Versanis.pl

Versanis Bio - Atlas Venture
Versanis Bio - Atlas Venture

Palma large pot stand. | Versanis.en
Palma large pot stand. | Versanis.en

Lloyd Klickstein - Chief Scientific Officer - Versanis Bio | LinkedIn
Lloyd Klickstein - Chief Scientific Officer - Versanis Bio | LinkedIn

Versanis Bio (@VersanisBio) / Twitter
Versanis Bio (@VersanisBio) / Twitter

Versanis Bio Company Profile: Financials, Valuation, and Growth | PrivCo
Versanis Bio Company Profile: Financials, Valuation, and Growth | PrivCo

Versanis Bio Announces $70 Million Series A | citybiz
Versanis Bio Announces $70 Million Series A | citybiz